Boston Scientific Corporation (BSX) Shares are Down -0.04%

Boston Scientific Corporation (BSX) : During the past 4 weeks, traders have been relatively bearish on Boston Scientific Corporation (BSX), hence the stock is down -0.76% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.57% relative to the S&P 500. The 4-week change in the price of the stock is -2.77% and the stock has fallen -0.04% in the past 1 week.

The stock has recorded a 20-day Moving Average of 1.9% and the 50-Day Moving Average is 1.8%.The 200 Day SMA reached 13.79% Boston Scientific Corporation is up 4.49% in the last 3-month period. Year-to-Date the stock performance stands at 27.44%.


Boston Scientific Corporation (BSX) : The most positive equity analysts on Boston Scientific Corporation (BSX) expects the shares to touch $30, whereas, the least positive believes that the stock will trade at $20 in the short term. The company is covered by 18 Wall Street Brokerage Firms. The average price target for shares are $26.08 with an expected fluctuation of $2.99 from the mean.

For the current week, the company shares have a recommendation consensus of Buy. Boston Scientific Corporation (NYSE:BSX): stock was range-bound between the intraday low of $23.375 and the intraday high of $23.68 after having opened at $23.57 on Fridays session. The stock finally closed in the red at $23.57, a loss of -0.51%. The stock remained in the red for the whole trading day. The total traded volume was 13,251,776 shares. The stock failed to cross $23.68 in Fridays trading. The stocks closing price on Thursday was $23.62.

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Womens Health, and Neuromodulation.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.